Pages that link to "Q33796975"
Jump to navigation
Jump to search
The following pages link to Emerging genetic therapies to treat Duchenne muscular dystrophy (Q33796975):
Displaying 27 items.
- Drug treatment of Duchenne muscular dystrophy: available evidence and perspectives (Q24601770) (← links)
- Sarcopenia: pharmacology of today and tomorrow (Q27687696) (← links)
- Nutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the Conjecture (Q28072269) (← links)
- Composite biomarkers for assessing Duchenne muscular dystrophy: an initial assessment (Q30392522) (← links)
- Parathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation (Q30580472) (← links)
- Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy. (Q30983066) (← links)
- Identification and characterization of small molecules that inhibit nonsense-mediated RNA decay and suppress nonsense p53 mutations (Q33693359) (← links)
- Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies (Q33961107) (← links)
- Gene therapy for inherited muscle diseases: where genetics meets rehabilitation medicine (Q34340857) (← links)
- Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients (Q34555477) (← links)
- Carbamylated erythropoietin does not alleviate signs of dystrophy in mdx mice (Q34674989) (← links)
- Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy (Q35069526) (← links)
- mdx(⁵cv) mice manifest more severe muscle dysfunction and diaphragm force deficits than do mdx Mice (Q35474357) (← links)
- Stop codon read-through with PTC124 induces palmitoyl-protein thioesterase-1 activity, reduces thioester load and suppresses apoptosis in cultured cells from INCL patients (Q35561773) (← links)
- The correlation analysis of functional factors and age with duchenne muscular dystrophy (Q35843560) (← links)
- Accurate Quantitation of Dystrophin Protein in Human Skeletal Muscle Using Mass Spectrometry (Q36812936) (← links)
- Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents (Q36925191) (← links)
- Engineering skeletal muscle tissue--new perspectives in vitro and in vivo (Q37811062) (← links)
- Control of gene expression by translational recoding. (Q37975583) (← links)
- Being ambulatory does not secure respiratory functions of Duchenne patients (Q38804184) (← links)
- Electrical impedance myography for the assessment of children with muscular dystrophy: a preliminary study. (Q43077577) (← links)
- Morphological Characterization of the Myenteric Plexus of the Ileum and Distal colon of Dogs Affected by Muscular Dystrophy (Q48144419) (← links)
- Genetic analysis of the dystrophin gene in children with Duchenne and Becker muscular dystrophies (Q51383798) (← links)
- Oligonucleotide therapeutics in neurodegenerative diseases (Q51737325) (← links)
- Functional Mixed-Effects Modeling Of Longitudinal Duchenne Muscular Dystrophy Electrical Impedance Myography Data Using State-Space Approach (Q58554471) (← links)
- Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up (Q61853276) (← links)
- Antisense oligonucleotides: A primer (Q64096491) (← links)